You're reading the free version. Trader adds the live tape and alerts.
Start tracking
SYRE Sale Disclosure
Sloan Sheldon · SEC Form 4 · Filed Jul 2, 2026
Sale
Calculated transaction value
$162.02K
Sloan Sheldon Chief Medical Officer
SYRE
Spyre Therapeutics
SYRE
Transaction date
Jul 1, 2026
Public filing date
Jul 2, 2026
Filing lag
Filed 1 day later
SYRE daily price context
Close on/before transaction
$88.89
Jul 1, 2026
First close after public filing
$88.74
Jul 6, 2026
30-day return after filing
+6.98%
Through Aug 3, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 1,834 shares @ $88.34
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001636282-26-000087
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$959.75K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Spyre Therapeutics, Inc. SYRE | Exercise | Jul 1, 2026 | $228.85K |
| Spyre Therapeutics, Inc. SYRE | Sale | Jul 1, 2026 | $568.88K |
| Spyre Therapeutics, Inc. SYRE Current | Sale | Jul 1, 2026 | $162.02K |
| Spyre Therapeutics, Inc. SYRE | Exercise | Jul 1, 2026 | $0 |